Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*

Derek C. Angus, Walter T. Linde-Zwirble, Gilles Clermont, Daniel E. Ball, Bruce R. Basson, E. Wesley Ely, Pierre-Francois Laterre, Jean-Louis Vincent, Gordon Bernard, Ben van Hout
2003 Critical Care Medicine  
doi:10.1097/00003246-200301000-00001 pmid:12544986 fatcat:ojkcdedfvfc2jolrvghzzjfinu